Hepatitis C in methadone maintenance patients: prevalence and public policy implications.

J Addict Dis 2001 ;20(1):19-31

Bi-Valley Medical Clinic, University of California, Davis, USA.

Objective: This study measured the extent and examined implications of hepatitis C (HCV) infection in a methadone maintenance treatment (MMT) population.

Method: Four hundred and sixty patients were tested for HCV-Ab, hepatic enzymes and bilirubin, HCV-RNA, and hepatitis B antibody.

Results: Overall, 87% of this population had evidence of HCV-Ab. Among drug injectors (IDU), 96% were HCV-Ab positive. Among a subset of Laotian opium-smoking patients prevalence was only 11%. Sixty-two percent of patients with HCV-Ab had detectable HCV-RNA. Only 41% had elevated hepatic enzymes, and 5% had elevated bilirubin levels. All age groups were equally infected. Systemic problems in screening and treating HCV in drug users were identified.

Conclusion: HCV infection poses significant long-term health risks for this population. Harm reduction interventions aimed at reducing transmission of HCV and other needle-related infectious disease deserves more consideration.

Download full-text PDF

Source
http://dx.doi.org/10.1300/J069v20n01_03DOI Listing
July 2001
13 Reads

Publication Analysis

Top Keywords

patients prevalence
8
hepatic enzymes
8
methadone maintenance
8
hcv infection
8
hcv-ab detectable
4
detectable hcv-rna
4
patients hcv-ab
4
percent patients
4
sixty-two percent
4
hcv-rna 41%
4
41% elevated
4
bilirubin levels
4
levels age
4
elevated bilirubin
4
enzymes elevated
4
elevated hepatic
4
11% sixty-two
4
prevalence 11%
4
drug injectors
4
injectors idu
4

References

(Supplied by CrossRef)

Maddrey W C et al.
Disease-A-Month 1993

Tong M J et al.
West J Med 1996

Zeldis J B et al.
West J Med 1992

Newmeyer J. et al.
Mid City Numbers (San Francisco) 1995

Similar Publications